Pictet Asset Management (UK)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Pictet Asset Management (UK)’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$14M	Sell	99,155 -252,400	-72%	-$28.5M	0.02%	602
2021 Q1	$35M	Sell	351,555 -1,423	-0.4%	-$166K	0.04%	403
2020 Q4	$43.6M	Sell	352,978 -115,400	-25%	-$15.2M	0.06%	328
2020 Q3	$45.6M	Buy	468,378 +135,403	+41%	+$16.9M	0.07%	287
2020 Q2	$52M	Buy	332,975 +68,601	+26%	+$10.4M	0.09%	249
2020 Q1	$38.2M	Buy	264,374 +113,312	+75%	+$21.9M	0.08%	254
2019 Q4	$30.9M	Buy	+151,062	New	+$27.6M	0.05%	358

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Pictet Asset Management (UK)'s RETA Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) stake by 72% in Q2 2021, selling an estimated $28.5M and leaving 99,155 shares worth $14M. The position accounts for 0.02% of the portfolio, ranked #602.

Pictet Asset Management (UK) first reported a position in RETA in Q4 2019 and has held it in 7 quarters since. The position peaked at $52M in Q2 2020. 194 funds tracked by Wall St. Rank hold RETA as of Q2 2021.

Pictet Asset Management (UK) held 99,155 shares of Reata Pharmaceuticals, Inc. Class A Common Stock worth $14M as of Q2 2021.
Pictet Asset Management (UK) sold 252,400 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q2 2021, an estimated $28.5M.
Reata Pharmaceuticals, Inc. Class A Common Stock made up 0.02% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #602 holding.
Pictet Asset Management (UK) first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2019 and has held it in 7 quarters since.
Pictet Asset Management (UK)'s Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $52M in Q2 2020.
194 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.